Trial
NCT00004878
Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
—
Condition
Graft Versus Host Disease
Intervention
therapeutic allogeneic lymphocytes
Why stopped
study never opened
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-31